Antithrombin III. Theory and clinical applications. H. P. Smith Memorial Lecture.
Antithrombin III is one of the main inhibitors in the blood coagulation mechanisms. Thrombin and factor Xa are slowly inactivated by it, as well as other serine proteinases of the coagulation mechanisms. Heparin tremendously accelerates the inhibitory function of antithrombin III. In the process antithrombin III activity is also reduced. Heparin retards the thrombin-fibrinogen reaction, but otherwise the effectiveness of heparin as an anticoagulant depends on antithrombin III in laboratory experiments, as well as in therapeutics. The activation of prothrombin is inhibited, and any thrombin or other vulnerable protease that might generate becomes inactivated. The measurement of antithrombin III concentration in blood is now achieved by research methods, as well as by methods that are practical for routine use. The tests require either thrombin or factor Xa as substrate, and could be specific for antithrombin III. There are congenital as well as acquired deficiencies of antithrombin III. The inhibitor is also found in tissues.
D000991:Antithrombins / Q000032:analysis / Q000502:physiology*; D001777:Blood Coagulation; D005170:Factor X / Q000502:physiology; D005337:Fibrin / Q000502:physiology; D006801:Humans; D013917:Thrombin / Q000502:physiology
D000991:Antithrombins; D005170:Factor X; D005337:Fibrin; D013917:Thrombin